Unlocking genetic commonalities between hypopharyngeal cancer and EGFR‐mutated lung adenocarcinoma using bioinformatics analysis, we identified 10 key hub genes suggesting potential therapeutic molecules for both diseases. This evidence concerns the gene EGFR and lung adenocarcinoma.